Printer Friendly

ZYNAXIS APPOINTS KEITH MANSFORD, PH.D. TO BOARD OF DIRECTORS

 MALVERN, Pa., Nov. 17 ~PRNewswire~ -- Zynaxis, Inc. (NASDAQ: ZN XS) today announced the appointment of Keith R.L. Mansford Ph.D to its board of directors. Dr. Mansford is currently the chairman of the Bio-Pharmaceutical Practice for Howard Fisher Associates, an executive search firm.
 Prior to joining HFA, this year, Dr. Mansford enjoyed a long and distinguished career at Beecham Pharmaceuticals, which subsequently became SmithKline Beecham. He was named chairman of research and development at the company in 1989 and before that, held the position of managing director of Beecham Pharmaceuticals-research and medical. Dr. Mansford joined Beecham in 1954. He became a board member in 1984.
 Dr. Mansford was a key team member in the negotiations that led to the merger between SmithKline and Beecham. He is a member of the Parliamentary and Scientific Committee, at the University of Buckingham, as well as an advisory council member of the Management Center of Europe.
 Thomas Cekoric Jr., president and CEO of Zynaxis stated: "We are extremely pleased to welcome Dr. Keith Mansford to our board of directors. His worldwide experience in the pharmaceutical industry will be of great value in the further development of the Zynaxis drug delivery technology."
 Zynaxis, Inc. is a biotechnology company engaged in the development of new therapeutic drug delivery systems and advanced cellular diagnostic systems.
 -0- 11~17~92
 ~CONTACT: Thomas Cekoric Jr., president and CEO of Zynaxis, Inc,, 215-889-2200, or Susan Sherman of Cameron Associates, 212-644-9560, for Zynaxis, Inc.~
 (ZNXS)


CO: Zynaxis, Inc. ST: Pennsylvania IN: MTC SU: PER

TS-OS -- NY037 -- 1800 11~17~92 11:34 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 17, 1992
Words:263
Previous Article:PARAMOUNT COMMUNICATIONS ANNOUNCES DIVIDEND
Next Article:ZYNAXIS APPOINTS ALAN STEIGROD TO BOARD OF DIRECTORS
Topics:


Related Articles
WALTER BRANDES JOINS ZYNAXIS AS VICE PRESIDENT OF SALES AND MARKETING
MICHAEL CHRISTIE, PH.D. JOINS ZYNAXIS AS VICE PRESIDENT OF PROCESS DEVELOPMENT
ZYNAXIS APPOINTS ALAN STEIGROD TO BOARD OF DIRECTORS
PAUL K. HORAN TO CONTINUE AS CHIEF SCIENTIFIC ADVISOR TO ZYNAXIS
ZYNAXIS ANNOUNCES PROMOTION OF DR. MUIRHEAD AND RESCHEDULES DIAGNOSTIC PRODUCT CLINICALS
ZYNAXIS APPOINTS MARTYN GREENACRE PRESIDENT AND CEO
MARTYN GREENACRE ASSUMES CHAIRMAN OF THE BOARD POSITION OF ZYNAXIS
ZYNAXIS REPORTS THIRD QUARTER 1994 FINANCIAL RESULTS
ZYNAXIS REPORTS PROMISING DATA ON DRUG DELIVERY TECHNOLOGY TO PREVENT RESTENOSIS
Confidence stirs move.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters